June 22, 2026 Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion
June 22, 2026 Xeriant Sets Up Next Production Run of NEXBOARD™ Following Class A Fire Rating and NFPA 286 Fire Testing Certification
June 22, 2026 Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants
